Zingoni et al., have shown that both MIC release and ADAM10 expression were upregulated in drug-induced multiple myeloma senescent cells, suggesting for the first time that soluble NKG2D ligands are components of tumor cell SASP (35) (Figure 1A). The gene discussed is ADAM10; the disease is plasma cell myeloma.